DEAMIDIERTES INTERFERON-BETA

Patent europeic · EP1809662 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1809662
Numer da la dumonda
EP05818235
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
10-11-2005
Publitgà
25-07-2007
Concedì
26-11-2008
Stritgà
30-11-2014
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 14/565 (2006.01)
A61K 38/19 (2006.01)
A61P 25/28 (2006.01)
Prioritad
US 626837 P 10.11.2004
Dumonda PCT
PCT/US2005/040758 10.11.2005
Publicaziun PCT
WO2006/053134 18.05.2006
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 17-06-2015

    Stritgà, taxa betg pajada

    Published in Swissreg on 17.06.2015

  2. 24-02-2009

    Represchentant inscrit

    Representative
    Novartis AG, Lichtstrasse 35, 4056 Basel

    Published in Swissreg on 24.02.2009

  3. 26-11-2008

    Concedì

    Published in Swissreg on 26.11.2008

Partidas

Possessur

Novartis Vaccines and Diagnostics, Inc.

4560 Horton Street, Emeryville, CA 94608-2916, US

Represchentant

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventur

FURUYA, Kenji

Emeryville, California 94608-2916, US

JOHNSON-JACKSON, Deborah

Emeryville, California 94608-2916, US

RUSCIO, Diana, Tierra

Emeryville, California 94608-2916, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.